Methamphetamines clinical trials at UCSF
2 in progress, 1 open to eligible people
Ketamine-Assisted Recovery for Methamphetamine Use Disorder & HIV
open to eligible people ages 18-69
The goal of this clinical trial is to learn whether it is possible to use intramuscular (IM) ketamine in combination with psychotherapy to treat moderate-to-severe methamphetamine use disorder (MeUD) in publicly insured patients with or at-risk for…
San Francicso, California
Intermittent Oral Naltrexone Enhanced With an Ecological Momentary Intervention for Methamphetamine-using MSM
Sorry, in progress, not accepting new patients
This is a double-blind, placebo-controlled phase 2b trial in which 54 MSM who use meth will be randomly assigned (2:1) to receive 12 weeks of as-needed intermittent oral naltrexone 50 mg enhanced with an EMA-informed EMI platform, or receive…
San Francisco, California
Our lead scientists for Methamphetamines research studies include Nicky Mehtani, MD MPH Glenn-Milo Santos, PhD, MPH.
Last updated: